Expression of other Bcl-2 family members, such as Bcl-2 and Bcl-xL, was not altered with DYRK1A knockdown or overexpression in NSCLC cells (Figure 1A and 1B). The gene discussed is DYRK1A; the disease is non-small cell lung carcinoma.